Overview Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 Status: Completed Trial end date: 2017-08-28 Target enrollment: Participant gender: Summary This study will evaluate longitudinal change of tau deposition as measured by flortaucipir F 18 uptake over time. Phase: Phase 2 Details Lead Sponsor: Avid Radiopharmaceuticals